Effects of florfenicol on early cytokine responses and survival in murine endotoxemia

International Immunopharmacology

Volumn 8, Issue 7, 2008, Pages 982-988

  Zhang, Xuemei ^a,b   Song, Yu ^a   Ci, Xinxin ^a   An, Na ^a   Fan, Junwen ^a   Cui, Junqing ^c   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

^b YANBIAN UNIVERSITY   (China)

^c PFIZER INC   (United States)

Author keywords

Cytokines; Endotoxemia; Florfenicol; LPS; NF B

Indexed keywords

CYTOKINE; FLORFENICOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOPLASM; DRUG EFFECT; ENDOTOXEMIA; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SINGLE DRUG DOSE; SURVIVAL;

ANIMALS; ANTI-BACTERIAL AGENTS; CELLS, CULTURED; CYTOKINES; ENDOTOXEMIA; FEMALE; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; THIAMPHENICOL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 43649091662     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.02.015     Document Type: Article

References (30)

1. Schultz M.J., Speelman P., Zaat S., van Deventer S.J., and Van der Poll T. Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood. Antimicrob Agents Chemother 42 (1998) 1605-1609
2. Shapira L., Soskolne W.A., Houri Y., Barak V., Halabi A., and Stabholz A. Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect Immun 64 (1996) 825-828
3. Cao X.Y., Dong M., Shen J.Z., and Wu B.B. Tilmicosin and tylosin have anti-inflammatory properties via modulation of COX-2 and iNOS gene expression and production of cytokines in LPS-induced macrophages and monocytes. Int J Antimicrob Agents 27 (2006) 431-438
4. Purswani M., Eckert S., Arora H., Johann-Liang R., and Noel G.J. The effect of three broad-spectrum antimicrobials on mononuclear cell responses to encapsulated bacteria: evidence for down-regulation of cytokine mRNA transcription by trovafloxacin. J Antimicrob Chemother 46 (2000) 921-929
5. Ziegeler S., Raddatz A., Hoff G., Buchinger H., Bauer I., Stockhausen A., et al. Antibiotics modulate the stimulated cytokine response to endotoxin in a human ex vivo, in vitro model. Acta Anaesthesiol Scand 50 (2006) 1103-1110
6. Shin S.J., Kang S.G., Nabin R., Kang M.L., and Yoo H.S. Evaluation of the antimicrobial activity of florfenicol against bacteria isolated from bovine and porcine respiratory disease. Vet Microbiol 106 (2005) 73-77
7. Priebe S., and Schwarz S. In vitro activities of florfenicol against bovine and porcine respiratory tract pathogens. Antimicrob Agents Chemother 47 (2003) 2703-2705
8. Aslan V., Maden M., Erganis O., Birdane F.M., and Corlu M. Clinical efficacy of florfenicol in the treatment of calf respiratory tract infections. Vet Q 24 (2002) 35-39
9. Ueda Y., Ohtsuki S., and Narukawa N. Efficacy of florfenicol on experimental actinobacillus pleuropneumonia in pigs. J Vet Med Sci 57 (1995) 261-265
10. O'Connor A.M., Wellman N.G., Evans R.B., and Roth D.R. A review of randomized clinical trials reporting antibiotic treatment of infectious bovine keratoconjunctivitis in cattle. Anim Health Res Rev 7 (2006) 119-127
11. Angelos J.A., Dueger E.L., George L.W., Carrier T.K., Mihalyi J.E., Cosgrove S.B., et al. Efficacy of florfenicol for treatment of naturally occurring infectious bovine keratoconjunctivitis. J Am Vet Med Assoc 216 (2000) 62-64
12. Saluk-Juszczak J., Wachowicz B., Saluk J.J., and Wachowicz B. The proinflammatory activity of lipopolysaccharide. Postepy Biochem 51 (2005) 280-287
13. Fujihara M., Muroi M., Tanamoto K., Suzuki T., Azuma H., and Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 100 (2003) 171-174
14. Mayeux P.R. Pathobiology of lipopolysaccharide. J Toxicol Environ Health 51 (1997) 415-435
15. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189 (1999) 1777-1782
16. Parrillo J.E., Parker M.M., Natanson C., Suffredini A.F., Danner R.L., Cunnion R.E., et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113 (1990) 227-242
17. Muchamuel T., Menon S., Pisacane P., Howard M.C., and Cockayne D.A. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. J Immunol 158 (1997) 2898-2903
18. Remick D.G., Kunkel R.G., Larrick J.K., and Kunkel S.L. Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest 56 (1987) 583-590
19. Beutler B., and Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem 57 (1988) 505-518
20. Dinarello C.A. Interleukin-1. Rev Infect Dis 6 (1984) 51-95
21. Takeda K., and Akira S. Regulation of innate immune responses by Toll-like receptors. Jpn J Infect Dis 54 (2001) 209-219
22. Purswani M.U., Eckert S.J., Arora H.K., and Noel G.J. Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine responses in a murine in vivo model. J Antimicrob Chemother 50 (2002) 51-58
23. Shapira L., Barak V., Soskolne W.A., Halabi A., and Stabholz A. Effects of tetracyclines on the pathologic activity of endotoxin: in vitro and in vivo studies. Adv Dent Res 12 (1998) 119-122
24. Katsuno G., Takahashi H.K., Iwagaki H., Sugita S., Mori S., Saito S., et al. The effect of ciprofloxacin on CD14 and toll-like receptor-4 expression on human monocytes. Shock 25 (2006) 247-253
25. Fiorentino D.F., Zlotnik A., Mosmamm T.R., Howard M., and O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 146 (1991) 3444-3451
26. Berg D.J., Kühn R., Rajewsky K., Müller W., Menon S., Davidson N., et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96 (1995) 2339-2347
27. Mutschler D., Wikstrom G., Lind L., Larsson A., Lagrange A., and Eriksson M. Etanercept reduces late endotoxin-induced pulmonary hypertension in the pig. J Interferon Cytokine Res 26 (2006) 661-667
28. Souza D.G., Ferreira F.L., Fagundes C.T., Amaral F.A., Vieira A.T., Lisboa R.A., et al. Effects of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in a model of intestinal reperfusion injury in mice. Eur J Pharmacol 571 (2007) 72-80
29. Guha M., and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13 (2001) 85-94
30. Tian B., and Brasier A.R. Identification of a nuclear factor kappa B-dependent gene network. Recent Prog Horm Res 58 (2003) 95-130